Potential Factors Affected Safety and Efficacy of Transcatheter Plug Closure for Pediatric Hemoptysis with Anomalous Bronchial Arteries

Abstract EN

Objective.

To evaluate the safety and efficacy of interventional care in pediatric hemoptysis for anomalous bronchial arteries (BAs) and to identify the potential factors resulting in hemoptysis recurrence.

Methods.

20 children complained of hemoptysis were diagnosed with anomalous BAs.

All patients received transcatheter plug occlusion in Department of Cardiology, Children’s Hospital of Chongqing Medical University.

The safety and efficacy were evaluated according to clinical symptoms and images monitoring of enrolled subjects grouped as recurrence group and nonrecurrence group.

The potential factors causing hemoptysis recurrence were reviewed and summarized.

Results.

No deaths were recorded in a follow-up.

Otherwise, hemoptysis recurrence was found in 8 subjects for 14 times, accounting for about 40%.

Compared with nonrecurrence group, it indicated a statistical significance in hemoglobin levels (P=0.049), mycoplasma pneumonia particle assays (MP-PA) titers (P=0.030), and number of anomalous BAs (P=0.020).

Meanwhile, 50% recurrent scenarios were associated with a respiratory infection by microbiological assessment before transcatheter plug occlusion.

The repeat occlusion was applied for unclosed BAs leading to visual recurrent hemoptysis, the average interval time of which was 5.4 ± 3.6 mon.

Conclusion.

The data from this retrospective study have shown that transcatheter plug occlusion is a relatively safe procedure with a low mortality.

The number of abnormal BAs has been identified as a highly significant predictor of recurrence, and the role of MP and other potential factors should be verified in a multicenter, larger sample size, and randomized controlled trial.